ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 63 filers reported holding ADC THERAPEUTICS SA in Q4 2022. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,410,000 | -39.4% | 500,000 | 0.0% | 0.06% | -25.9% |
| Q2 2022 | $3,975,000 | -45.9% | 500,000 | 0.0% | 0.08% | -44.4% |
| Q1 2022 | $7,345,000 | -27.3% | 500,000 | 0.0% | 0.15% | -1.9% |
| Q4 2021 | $10,100,000 | -25.6% | 500,000 | 0.0% | 0.16% | -12.4% |
| Q3 2021 | $13,580,000 | +11.5% | 500,000 | 0.0% | 0.18% | +42.4% |
| Q2 2021 | $12,175,000 | -0.2% | 500,000 | 0.0% | 0.12% | +3.3% |
| Q1 2021 | $12,205,000 | -23.7% | 500,000 | 0.0% | 0.12% | -4.7% |
| Q4 2020 | $16,005,000 | -3.0% | 500,000 | 0.0% | 0.13% | +1.6% |
| Q3 2020 | $16,495,000 | -29.5% | 500,000 | 0.0% | 0.12% | -41.6% |
| Q2 2020 | $23,405,000 | – | 500,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,186,215 | $5,718,000 | 3.34% |
| Blue Owl Capital Holdings LP | 733,568 | $3,536,000 | 1.53% |
| Redmile Group, LLC | 7,512,029 | $36,208,000 | 1.40% |
| GCM Grosvenor Holdings, LLC | 735,471 | $3,545,000 | 0.84% |
| Prosight Management, LP | 247,630 | $1,194,000 | 0.64% |
| Indie Asset Partners, LLC | 93,839 | $452,000 | 0.46% |
| MPM BioImpact LLC | 334,384 | $1,612,000 | 0.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,390,297 | $11,521,000 | 0.23% |
| Eventide Asset Management | 1,879,959 | $9,061,000 | 0.18% |
| APOGEM CAPITAL LLC | 17,405 | $84,000 | 0.08% |